728 related articles for article (PubMed ID: 33512345)
1. FDA authorizes Moderna COVID-19 vaccine.
Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345
[No Abstract] [Full Text] [Related]
2. FDA authorizes Pfizer-BioNTech COVID-19 vaccine.
Med Lett Drugs Ther; 2021 Jan; 63(1615):1-2. PubMed ID: 33646996
[No Abstract] [Full Text] [Related]
3. FDA authorizes Johnson & Johnson COVID-19 vaccine.
Med Lett Drugs Ther; 2021 Mar; 63(1620):41-42. PubMed ID: 33976088
[No Abstract] [Full Text] [Related]
4. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
5. Messengers of hope.
Nat Biotechnol; 2021 Jan; 39(1):1. PubMed ID: 33376248
[TBL] [Abstract][Full Text] [Related]
6. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.
Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1653-1656. PubMed ID: 33382675
[TBL] [Abstract][Full Text] [Related]
7. FDA authorizes first single-shot COVID-19 vaccine.
Mullard A
Nat Rev Drug Discov; 2021 Apr; 20(4):251. PubMed ID: 33707753
[No Abstract] [Full Text] [Related]
8. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.
;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(4):125-129. PubMed ID: 33507892
[TBL] [Abstract][Full Text] [Related]
9. Why emergency COVID-vaccine approvals pose a dilemma for scientists.
Cyranoski D
Nature; 2020 Dec; 588(7836):18-19. PubMed ID: 33230275
[No Abstract] [Full Text] [Related]
10. Vaccine safety - is the SARS-CoV-2 vaccine any different?
Tau N; Yahav D; Shepshelovich D
Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
[TBL] [Abstract][Full Text] [Related]
11. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
[TBL] [Abstract][Full Text] [Related]
12. In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines.
Med Lett Drugs Ther; 2021 Jul; 63(1629):e9. PubMed ID: 34544112
[No Abstract] [Full Text] [Related]
13. How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
Shakir S; Lane S; Davies M
Drug Saf; 2021 Jan; 44(1):1-5. PubMed ID: 33219926
[No Abstract] [Full Text] [Related]
14. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021.
Oliver SE; Gargano JW; Scobie H; Wallace M; Hadler SC; Leung J; Blain AE; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; MacNeil J; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(9):329-332. PubMed ID: 33661860
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2 vaccines in patients with SLE.
Tang W; Askanase AD; Khalili L; Merrill JT
Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33685998
[TBL] [Abstract][Full Text] [Related]
16. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.
Oliver SE; Gargano JW; Marin M; Wallace M; Curran KG; Chamberland M; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1922-1924. PubMed ID: 33332292
[TBL] [Abstract][Full Text] [Related]
17. Feds update immunization advice with Moderna vaccine approval.
Vogel L
CMAJ; 2021 Jan; 193(3):E108-E109. PubMed ID: 33462152
[No Abstract] [Full Text] [Related]
18. COVID-19 vaccines approved in the European Union: current evidence and perspectives.
Bellino S
Expert Rev Vaccines; 2021 Oct; 20(10):1195-1199. PubMed ID: 34338126
[No Abstract] [Full Text] [Related]
19. Emergency Use Authorization of COVID-19 Vaccine: Implications for Worker Communities.
Culp K; Dukes KC; Cowin C; Sinnwell E
Workplace Health Saf; 2021 Apr; 69(4):152-153. PubMed ID: 33787400
[No Abstract] [Full Text] [Related]
20. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old.
Med Lett Drugs Ther; 2021 May; 63(1625):81. PubMed ID: 34101717
[No Abstract] [Full Text] [Related]
[Next] [New Search]